Nanoparticle-Mediated Wild-Type p53 Gene Delivery Results in Sustained Antiproliferative Activity in Breast Cancer Cells-Reference-Cited by-同舟云学术

Nanoparticle-Mediated Wild-Type p53 Gene Delivery Results in Sustained Antiproliferative Activity in Breast Cancer Cells

Published:2004-03-31 Issue:3 Volume:1 Page:211-219
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Prabha Swayam¹,Labhasetwar Vinod¹

Affiliation:

1. Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, Nebraska 68198-6025, and Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska 68198-4525

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/mp049970%2B

Reference43 articles.

1. Gene delivery with synthetic (non viral) carriers

2. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration

3. Soluble Biodegradable Polymer-Based Cytokine Gene Delivery for Cancer Treatment

4. Biodegradable polymer-based interleukin-12 gene delivery: role of induced cytokines, tumor infiltrating cells and nitric oxide in anti-tumor activity

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nano-drug delivery system for the treatment of multidrug-resistant breast cancer: Current status and future perspectives;Biomedicine & Pharmacotherapy;2024-10

2. A REVIEW OF NANOPARTICLE INNOVATIONS IN CANCER THERAPY: IMPLICATIONS, TARGETING MECHANISMS AND CLINICAL PROSPECTS;International Journal of Applied Pharmaceutics;2024-05-07

3. Codelivery of Doxorubicin and p53 Gene by β-Cyclodextrin-Based Supramolecular Nanoparticles Formed via Host–Guest Complexation and Electrostatic Interaction;Biomacromolecules;2024-04-08

4. An Updated Insight into Phytomolecules and Novel Approaches used in the Management of Breast Cancer;Current Drug Targets;2024-02

5. Novel Strategies for Overcoming Drug Resistance;Drug Resistance in Cancer: Mechanisms and Strategies;2024